Data availability
The raw data that support the findings of this study are available upon reasonable request from the corresponding author.
References
Ando T, Riku Y, Akagi A, Miyahara H, Hirano M, Ikeda T, Yabata H, Koizumi R, Oba C, Morozumi S, Yasui K, Goto A, Katayama T, Sakakibara S, Aiba I, Sakai M, Konagaya M, Mori K, Ito Y, Yuasa H, Nomura M, Porto KJL, Mitsui J, Tsuji S, Mimuro M, Hashizume Y, Katsuno M, Iwasaki Y, Yoshida M (2022) Multiple system atrophy variant with severe hippocampal pathology. Brain Pathol 32:e13002
Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Durr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670–676
Jellinger KA, Seppi K, Wenning GK (2005) Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov Disord 20:S29–S36
Lee YH, Ando T, Lee JJ, Baek MS, Lyoo CH, Kim SJ, Kim M, Cho JW, Sohn YH, Katsuno M, Watanabe H, Yoshida M, Lee PH (2020) Later-onset multiple system atrophy: a multicenter Asian study. Mov Disord 35:1692–1693
Sekiya H, Koga S, Otsuka Y, Chihara N, Ueda T, Sekiguchi K, Yoneda Y, Kageyama Y, Matsumoto R, Dickson DW (2022) Clinical and pathological characteristics of later onset multiple system atrophy. J Neurol. https://doi.org/10.1007/s00415-022-11067-1
Trojanowski JQ, Revesz T, Neuropathology Working Grp MSA (2007) Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol Appl Neurobiol 33:615–620
Acknowledgements
We would like to thank all patients and their families as well as clinicians who referred patients to our institute. We also wish to express our gratitude to Kenji Kohtani, Toshiaki Mizuno, Chizuko Sano, and Chieko Uno for their technical support.
Funding
MY was supported by a grant from Intramural Research Grant (30-8) for Neurological and Psychiatric Disorders of NCNP. YR was supported by a grant from JSPS KAKENHI (no. JP20K16586). YI was supported by Grants-in-Aid from the Research Committee of CNS Degenerative Diseases; Research on Policy Planning and Evaluation for Rare and Intractable Diseases; Health, Labour, and Welfare Sciences Research Grants; and the Ministry of Health, Labour, and Welfare, Japan. This research was partly supported by AMED under Grant Number JP21wm0425019 (MY).
Author information
Authors and Affiliations
Contributions
Conceptualization: TA; methodology: TA, YR, and MY; investigation: TA, YR, AA, HM, JS, MY, and YI; writing, original draft: TA; writing, review, and editing: YR, MK, MY, and YI; supervision: MK, MY, and YI.
Corresponding author
Ethics declarations
Conflicts of interest
The authors report no competing interests.
Ethical approval
Written informed consent was obtained from the patients’ relatives before autopsies. All human studies were approved by the research ethics committee of the Aichi Medical University.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ando, T., Riku, Y., Akagi, A. et al. Clinical diagnosis sensitivity of neuropathologically established multiple system atrophy in Japan. J Neurol 269, 5162–5164 (2022). https://doi.org/10.1007/s00415-022-11122-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-022-11122-x